CAT
Catalase
Also known as: CATA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P04040
- Gene
- CAT
- Ensembl
- ENSG00000121691
- Chromosome
- 11
- Canonical length
- 527 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes catalase, a key antioxidant enzyme in the bodies defense against oxidative stress. Catalase is a heme enzyme that is present in the peroxisome of nearly all aerobic cells. Catalase converts the reactive oxygen species hydrogen peroxide to water and oxygen and thereby mitigates the toxic effects of hydrogen peroxide. Oxidative stress is hypothesized to play a role in the development of many chronic or late-onset diseases such as diabetes, asthma, Alzheimer's disease, systemic lupus erythematosus, rheumatoid arthritis, and cancers. Polymorphisms in this gene have been associated with decreases in catalase activity but, to date, acatalasemia is the only disease known to be caused by this gene. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
527 residues, UniProt reviewed canonical sequence.
>P04040|CAT
1 MADSRDPASD QMQHWKEQRA AQKADVLTTG AGNPVGDKLN VITVGPRGPL LVQDVVFTDE
61 MAHFDRERIP ERVVHAKGAG AFGYFEVTHD ITKYSKAKVF EHIGKKTPIA VRFSTVAGES
121 GSADTVRDPR GFAVKFYTED GNWDLVGNNT PIFFIRDPIL FPSFIHSQKR NPQTHLKDPD
181 MVWDFWSLRP ESLHQVSFLF SDRGIPDGHR HMNGYGSHTF KLVNANGEAV YCKFHYKTDQ
241 GIKNLSVEDA ARLSQEDPDY GIRDLFNAIA TGKYPSWTFY IQVMTFNQAE TFPFNPFDLT
301 KVWPHKDYPL IPVGKLVLNR NPVNYFAEVE QIAFDPSNMP PGIEASPDKM LQGRLFAYPD
361 THRHRLGPNY LHIPVNCPYR ARVANYQRDG PMCMQDNQGG APNYYPNSFG APEQQPSALE
421 HSIQYSGEVR RFNTANDDNV TQVRAFYVNV LNEEQRKRLC ENIAGHLKDA QIFIQKKAVK
481 NFTEVHPDYG SHIQALLDKY NAEKPKNAIH TFVQSGSHLA AREKANLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CAT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 1,138 nTPM
Expression across tissuesHPA
Tissue
- liver: 1,138 nTPM
- bone marrow: 385 nTPM
- kidney: 277 nTPM
- adipose tissue: 264 nTPM
- lung: 154 nTPM
- duodenum: 137 nTPM
Single-cell type
- hepatocytes: 582 nCPM
- erythrocyte progenitors: 463 nCPM
- neutrophil progenitors: 334 nCPM
- megakaryocyte-erythroid progenitors: 305 nCPM
- adipocytes: 272 nCPM
- monocyte progenitors: 233 nCPM
Immune cell
- eosinophil: 4,748 nTPM
- total PBMC: 398 nTPM
- myeloid DC: 354 nTPM
- classical monocyte: 325 nTPM
- non-classical monocyte: 300 nTPM
- neutrophil: 291 nTPM
Brain region
- white matter: 53 nTPM
- choroid plexus: 52 nTPM
- medulla oblongata: 44 nTPM
- hypothalamus: 31 nTPM
- midbrain: 31 nTPM
- spinal cord: 31 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CAT.
Disease | AllUniProt
Conditions CAT is implicated in, by any mechanism.
- Acatalasemia (ACATLAS) MIM:614097
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 84 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Acatalasemia, japanese type
- Acatalasia
ReferencesPubMed · IEDB
Publications for CAT from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
2008 · Scand J Rheumatol · RCR 1.9 · 70 citations - Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis.
1998 · Clin Exp Immunol · RCR 1.8 · 68 citations - High levels of autoantibodies against catalase and superoxide dismutase in nasopharyngeal carcinoma.
2009 · South Med J · RCR 0.1 · 4 citations - Identification of epitopes for cross-reaction, auto-reaction and autoantibodies to catalase.
2000 · J Autoimmun · RCR 0.1 · 4 citations - [Detection of serum catalase antibodies in patients with inflammatory rheumatic diseases by immobilized magnetic sorbents].
2008 · Klin Lab Diagn
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.05
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.08
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aerobic respiration
- cellular detoxification of hydrogen peroxide
- cellular response to growth factor stimulus
- cholesterol metabolic process
- hemoglobin metabolic process
- hydrogen peroxide catabolic process
- negative regulation of apoptotic process
- osteoblast differentiation
- positive regulation of cell division
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- response to activity
- response to cadmium ion
- response to estradiol
- response to ethanol
- response to fatty acid
- response to hydrogen peroxide
- response to hyperoxia
- response to hypoxia
- response to inactivity
- response to insulin
- response to L-ascorbic acid
- response to lead ion
- response to light intensity
- response to ozone
- response to phenylpropanoid
- response to reactive oxygen species
- response to vitamin A
- response to vitamin E
- response to xenobiotic stimulus
- triglyceride metabolic process
- ureteric bud development
- UV protection
- response to amitrole
Molecular functions
- aminoacylase activity
- antioxidant activity
- catalase activity
- enzyme binding
- heme binding
- identical protein binding
- metal ion binding
- NADP binding
- oxidoreductase activity, acting on peroxide as acceptor
- protein homodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Catalase haem-binding site
- Catalase immune-responsive domain
- Catalase core domain
- Catalase, mono-functional, haem-containing
- Catalase superfamily
- Catalase active site
- Catalase, mono-functional, haem-containing, clades 1 and 3
- Catalase, clade 3
- Catalase
- Catalase-related immune-responsive
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CAT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CAT as an antibody target. Whether an autoantibody or antibody against CAT could matter depends on whether native CAT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CAT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CAT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...